Produktname:tert-butyl 3-(2-ethoxy-2-oxoethyl)azetidine-1-carboxylate
IUPAC Name:tert-butyl 3-(2-ethoxy-2-oxoethyl)azetidine-1-carboxylate
- CAS:158602-35-8
- Molekulare Formel:C12H21NO4
- Reinheit:95%+
- Katalognummer:CM107197
- Molekulargewicht:243.3
Nur für den Einsatz in Forschung und Entwicklung..
Produkt-Details
- CAS-Nr.:158602-35-8
- Molekulare Formel:C12H21NO4
- Schmelzpunkt:-
- SMILES-Code:O=C(N1CC(CC(OCC)=O)C1)OC(C)(C)C
- Dichte:
- Katalognummer:CM107197
- Molekulargewicht:243.3
- Siedepunkt:
- Mdl-Nr.:
- Lagerung:
Category Infos
- Azetidines
- Azetidines are an important class of saturated four-membered nitrogen-containing heterocyclic compounds. The research hotspots related to this structure mainly focus on two aspects: one is the research of pharmaceutical chemistry; the other is related to chiral azetidines, using rigid azetidine compounds as chiral ligands for asymmetric catalytic reactions. Many nitrogen-containing heterocycles play important roles in drug structures, and in many cases small structural changes can improve ligand selectivity and pharmacokinetic properties.
- Where to buy Azetidines
- Where to buy ADC-Cytotoxins? Chemenu Provide Azetidines with high quality and competitive price. Contact us Now.
Column Infos
- Amino Acids and Peptides
- Amino acids are organic compounds containing a basic amino group and an acidic carboxyl group. Because amino acids contain both amino and carboxyl groups, they can be polymerized in an end-to-end manner, removing a molecule of water to form a covalent amide bond or peptide bond. Many amino acids are linked together end to end to form a polypeptide. Amino acids and peptides are important components in the fields of medicine and life sciences.
- Emraclidine
- Emraclidine is a novel, brain-penetrant, highly selective M4 receptor positive allosteric modulator(PAM) in development for the treatment of schizophrenia.
We believe emraclidine has the potential to provide a significant medical advancement as the muscarinic acetylcholine pathway has long been associated with mediation of neurotransmitter imbalance and psychosis. Emraclidine is the only selective M4 receptor PAM currently in clinical development.